Pharma
Trevia (Sitagliptin Tablets USP 100 mg)
DPP-4 inhibitor; 100 mg Sitagliptin tablets for the management of Type 2 Diabetes.
Trevia (Sitagliptin Tablets USP 100 mg)
Trevia 100 mg contains Sitagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor designed to improve blood sugar control in adults with type 2 diabetes mellitus. It functions by protecting incretin hormones from degradation, which in turn signals the pancreas to produce more insulin and the liver to produce less glucose. It is intended for use alongside diet and exercise to manage glycemic levels. This medication is not suitable for patients with type 1 diabetes or diabetic ketoacidosis. Side effects may include nasopharyngitis, upper respiratory tract infection, and headache.
You May Also Like
Antihypertensive and alpha-2 agonist; 0.1 mg tablets for blood pressure and ADHD management.
Combination antidiabetic agent; 2.5 mg Linagliptin and 1000 mg Metformin tablets for Type 2 Diabetes management.
Combination DPP-4 inhibitor and Biguanide; 50 mg/850 mg Sitagliptin/Metformin tablets for Type 2 Diabetes.
High-strength immunosuppressant; 100 mg Cyclosporine soft gelatin capsules for transplant maintenance.